The Pandemic Evidence Collaboration in partnership EBMLive presents

Elevating Evidence-Based Healthcare in a Post-Pandemic World 2026

Conference Themes include but are not exclusive to:

• Enhancing evidence for public health emergencies
• Supporting the generation of high-quality evidence for public health emergencies.
• Fostering effective and efficient knowledge exchange for global public health emergencies.
• Inspiring policymakers and health system leaders to incorporate high-quality evidence into decision-making.
• Increasing public understanding of the benefits and harms of the use of NPIs during global health care emergencies in different environments.

Wiser evidence-based healthcare

• Addressing the issue of overdiagnosis and the effective use of diagnostic tests.
• Promoting value-based healthcare through identifying tests, procedures, and interventions that provide little or no net benefit or cause more harm than good.
• Production and translation of high-quality research evidence to support effective healthcare.
• Promoting sustainable, affordable healthcare that incudes

1. 1. Clinical sustainability – care that improves outcomes and avoids harm or waste.
   2. Economic sustainability – care that is cost-effective and financially viable for patients and systems.
   3. Environmental sustainability – reducing the carbon footprint, waste, and resource use of healthcare itself

Transforming the communication of health evidence and risk

• Effective communications through the media and social media for better understanding and use of evidence.
• How can patients, clinicians and policy-makers better understand and use evidence.
• Educating professionals, policy makers and the public to make better informed choices.
• Increasing healthcare practitioners’ awareness of evidence-based medicine and its role in effective healthcare.

Improving the quality and dissemination of research evidence

• Ensuring evidence is relevant, accessible and transparent – tackling issues such as publication bias, selective reporting and limited external validity trials.
• Reducing questionable research practices and conflicts of interest.
• Assessing the role of artificial intelligence in developing high-quality research evidence.
• Reducing waste in research that incudes
  1. Improving Study Design and Methods
  2. Addressing bias and confounding in research
  3. Transparency and reporting
  4. Industry and commercial influence

Call for Abstracts OPEN